Campaign News
VIVA! Communications shortlisted in upcoming PRIA Awards night – October 6, 2015
VIVA! Communications is pleased to be recognised for excellence in the upcoming Public Relations Institute of Australia’s (PRIA) industry award night, scheduled for tomorrow (Wednesday, October 7, 2015). This year, VIVA! Communications has been shortlisted as a finalist in PRIA’s 39th annual Golden Target Awards and State Awards for Excellence, attracting 170 entrants to 29…
Read MoreBe sun aware this summer by booking a Blooms The Chemist Skin Cancer SpotCheck today – October 1, 2015
More than 12,500 new cases of melanoma are diagnosed in Australia each year. According to the Melanoma Institute of Australia, skin cancer, including melanoma and non-melanoma skin cancers, is Australia’s most common cancer. This October, Blooms The Chemist Sun Awareness Clinics are helping to keep Aussies sun aware, by identifying moles and skin spots that…
Read MoreRecycling organs: a risky business or savvy strategy for tackling our national shortage of organ donors? September 11, 2015
With around 1,600 Australians on the organ donation waiting list at any given time, a shortage of organ donations across the nation has led doctors at Newcastle’s John Hunter Hospital to transplant willing dialysis patients with the recycled and diseased kidneys of cancer patients. Despite being an extremely risky procedure, according to the ABC (September…
Read MoreA Stroke Risk Assessment could save your life – September 9, 2015
This Stroke Risk Awareness Month we are posing the question – Are you at risk of stroke? Are you aware that stroke is the third most common cause of death in Australian men, ranking higher than prostate cancer, and the second most common cause of death in women, ranking higher than breast cancer. There’s a…
Read MoreA mother’s renewed appeal to the government to save her young daughter’s life – July 31, 2015
On December 1, 2014, the small aHUS Australian community celebrated with the PBS listing of Soliris (eculizumab) through Section 100: Highly Specialised Drugs Program for those who meet certain criteria, and the earmarking of $63 million in treatment funding over the next four years. Since then, our celebrations have begun to sour, as aHUS patients currently accessing…
Read More